An open-label study using the MedPulser electroporation system to treat cutaneous and subcutaneous foci of cancer

Trial Profile

An open-label study using the MedPulser electroporation system to treat cutaneous and subcutaneous foci of cancer

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Oct 2017

At a glance

  • Drugs Bleomycin (Primary)
  • Indications Skin cancer
  • Focus Therapeutic Use
  • Sponsors Inovio Pharmaceuticals
  • Most Recent Events

    • 14 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top